Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration

Yuya Kishino1, Koji Matsukawa2, Taisei Matsumoto2

  • 1Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.

Insights

Casein kinase 1δ (CK1δ) phosphorylation of fused in sarcoma (FUS) protein increases FUS solubility and reduces neurotoxicity in ALS models. This suggests CK1δ/CK1ε-mediated phosphorylation is a potential therapeutic target for FUS proteinopathies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Aberrant cytoplasmic accumulation of fused in sarcoma (FUS) protein is a key feature in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration.
  • The role of FUS post-translational modifications, particularly phosphorylation, in its neurotoxicity remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of casein kinase 1δ (CK1δ) phosphorylation on FUS solubility and neurotoxicity.
  • To explore the therapeutic potential of CK1δ/CK1ε-mediated phosphorylation in FUS proteinopathies.

Main Methods:

  • In vitro mass spectrometric analysis to identify FUS phosphorylation sites by CK1δ.
  • Cellular assays in human embryonic kidney 293 cells to assess FUS solubility after phosphorylation.
  • Transgenic Drosophila models overexpressing FUS (wild-type and ALS-mutant) with coexpression of CK1δ or Dco to evaluate neuroprotective effects.

Main Results:

  • CK1δ was identified to phosphorylate FUS at 10 serine/threonine residues in vitro.
  • Phosphorylation by CK1δ or CK1ε significantly enhanced FUS solubility in HEK293 cells.
  • Coexpression of CK1δ/Dco ameliorated FUS-induced retinal degeneration and extended lifespan in Drosophila models.

Conclusions:

  • CK1δ/CK1ε-mediated phosphorylation represents a novel regulatory mechanism for FUS assembly and toxicity.
  • Targeting CK1δ/CK1ε phosphorylation offers a potential therapeutic strategy for FUS proteinopathies like ALS.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
51.1K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.3K